3.90
5.80%
-0.24
Handel nachbörslich:
3.88
-0.02
-0.51%
Finanzdaten der Fate Therapeutics Inc-Aktie (FATE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
13.79%
1.676
|
1.944 | 0.933 | 58.98 | 44.36 |
Operating Expenses
|
6.52%
49.75
|
53.22 | 63.50 | 87.57 | 108.78 |
Benefits Costs and Expenses |
45.80
|
- | - | 77.86 | 100.72 |
Costs And Expenses |
13.95%
45.80
|
53.22 | 63.50 | 77.86 | 100.72 |
Operating Income/Loss |
6.25%
-48.08
|
-51.28 | -62.56 | -28.59 | -64.42 |
Income/Loss From Continuing Operations Before Tax |
2,370%
-44.12
|
1.944 | -52.76 | -18.88 | -56.36 |
Income/Loss From Continuing Operations After Tax |
2.32%
-44.12
|
-45.17 | -52.76 | -18.88 | -56.36 |
Net Income/Loss
|
2.32%
-44.12
|
-45.17 | -52.76 | -18.88 | -56.36 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.93%
0.0683
|
98.57 | 98.40 | 98.05 | 0.1331 |
Diluted Average Shares |
99.93%
0.0683
|
98.57 | 98.40 | 98.05 | 0.1331 |
Basic Earnings Per Share |
2.17%
-0.45
|
-0.46 | -0.54 | -0.19 | -0.58 |
Diluted Earnings Per Share |
2.17%
-0.45
|
-0.46 | -0.54 | -0.19 | -0.58 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):